Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


PHOENIX BIOTECHNOLOGY, INC.

PHOENIX BIOTECHNOLOGY, INC. Patent applications
Patent application numberTitlePublished
20120128798Method of Treating Neurological Conditions with Extract of Nerium Species or Thevetia Species - A method of treating neurological condition in a subject by administration of an extract, or fraction or sub-fraction thereof, of 05-24-2012
20110172172Method of Treating Neurological Conditions with Cardiac Glycoside - A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside to a subject. The cardiac glycoside can be present in a dosage form.07-14-2011
20100317541Method of Determining the Probability of a Therapeutic Response in Cancer Chemotherapy With Cardiac Glycoside - A prognostic assay and kit and method of use thereof are provided. The kit and assay are used to determine the likelihood of a diseased cell or tissue having a therapeutic response to treatment with a cardiac glycoside in a disease having an etiology associated with excessive cell proliferation. The kit and assay are used to determine the ratio of isoforms of the α subunit of Na, K-ATPase obtained from the diseased cell or tissue. The kit can be used to predict the therapeutic responsiveness of cancer or tumor in a subject to treatment with a cardiac glycoside. The kit and assay can be incorporated in a method of treating a disease or disorder having an etiology associated with excessive cell proliferation with a composition comprising a cardiac glycoside.12-16-2010
20080200401SCF Extract Containing Cardiac Glycoside - A supercritical fluid (SCF) extract of a cardiac glycoside-containing plant mass is provided. The extract can be included in a pharmaceutical composition containing an extract-solubilizing amount of solubilizer. Oleandrin is included within the extract when a cardiac glycoside-containing plant, such as 08-21-2008

Patent applications by PHOENIX BIOTECHNOLOGY, INC.